Omega-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS

Details for Australian Patent Application No. 2002363319 (hide)

Owner ALLERGAN, INC.

Inventors BURK, Robert, M.; HOLOBOSKI, Mark; POSNER, Mari, F.

Pub. Number AU-A-2002363319

PCT Number PCT/US02/34301

PCT Pub. Number WO2003/040126

Priority 60/338,838 05.11.01 US

Filing date 25 October 2002

Wipo publication date 19 May 2003

International Classifications

C07D 333/16 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 031/559

A61P 027/06 Drugs for disorders of the senses

Event Publications

19 June 2003 Complete Application Filed

  Priority application(s): 60/338,838 05.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002363319

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363320-Ultraviolet disinfecting apparatus

2002363318-Compounds and methods for treating transplant rejection